The response deadline has passed. Review the details for future reference or to track similar opportunities.
The Food and Drug Administration is procuring services for the development of a comparative assessment related to pulse field ablation. The key requirements include conducting a thorough analysis and providing insights on the technology's effectiveness and safety.
No description available
Get matched to contracts like this daily
Free AI-powered contract matching for your business.